Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Gilbert Lynn Marks currently holds 79,084 shares of AN2 Therapeutics, Inc. (ANTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gilbert Lynn Marks has been a net neutral trader of ANTX stock. They have purchased $0 and sold $0 worth of shares.
Gilbert Lynn Marks's most recent insider trade was on Apr 10, 2026, when they sold 3,775 shares at $0.00 per share.
Gilbert Lynn Marks serves as Executive at AN2 Therapeutics, Inc. (ANTX). They have executed 5 insider transactions totaling $0 over their tenure at the company.
Gilbert Lynn Marks holds the position of Executive at AN2 Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Gilbert Lynn Marks has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Gilbert Lynn Marks was on Apr 10, 2026, when they purchased $0 worth of ANTX shares. This transaction involved 3,775 shares at N/A per share.
Gilbert Lynn Marks currently owns 79,084 shares of AN2 Therapeutics, Inc. (ANTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Gilbert Lynn Marks's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Gilbert Lynn Marks has 5 Form 4 filings on record as an insider at AN2 Therapeutics, Inc..
Set alerts for Gilbert Lynn Marks and 40,000+ other insiders.